Safety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) for the Treatment of Persistent Macular Edema Secondary to Retinal Vein Occlusion in Eyes Previously Treated with Anti-Vascular Endothelial Growth Factors

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|10|2|145-151

ISSN： 1574-8863

Source： Current Drug Safety, Vol.10, Iss.2, 2015-07, pp. : 145-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy of macular oedema: meta‐analysis

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 42, Iss. 7, 2014-09 ,pp. : 637-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

The 1 year outcome of intravitreal dexamethasone implant for macular edema secondary to central retinal vein occlusion

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tomographic analysis of the retinal layers in diabetic macular edema treated with dexamethasone intravitreal implant

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravitreal bevacizumab: a viable treatment for bilateral central retinal vein occlusion with serous macular detachment secondary to Waldenström macroglobulinaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 431-434

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti‐vascular endothelial growth factors treatment of wet age‐related macular degeneration: from neurophysiology to cost‐effectiveness

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. A109, 2018-02 ,pp. : 1-46

John Wiley & Sons Inc

Access to resources Recommend Favorite